fbpx
QQQ
+ 7.05
312.29
+ 2.21%
DIA
+ 4.00
336.23
+ 1.18%
SPY
+ 6.32
403.85
+ 1.54%
TLT
+ 1.27
134.54
+ 0.94%
GLD
+ 1.54
169.61
+ 0.9%

Aphria One Step Closer To Merging With Tilray, Shareholders Overwhelmingly Approve The Deal

April 15, 2021 12:23 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Aphria One Step Closer To Merging With Tilray, Shareholders Overwhelmingly Approve The Deal

Aphria Inc. (TSX:APHA) (NASDAQ:APHA) confirmed Thursday it has satisfied one of the requirements for its merger with Tilray Inc. (NASDAQ:TLRY) after its shareholders approved the arrangement at a special meeting.

The special resolution approving the arrangement had to be endorsed by a minimum of two-thirds (66.6%) of the votes cast at the meeting. The merger got a 99.38% approval rate.

The Deal

Under the agreement, Aphria shareholders will obtain 0.8381 of a Tilray class 2 share for each Aphria share owned. Tilray shareholders keep their Tilray shares with no changes in ratios.

The merger was first announced back in December, when it was projected it would form the world’s largest company based on pro forma revenue. The deal was also praised by Cantor Fitzgerald’s analyst Pablo Zuanic, who said that it “makes sense” and that the Canadian cannabis sectors could use consolidation moves to help its oversupply issues.

The resulting company would keep the Tilray name and place Irwin Simon, Aphria’s CEO, as Chief Executive Officer.

See also: How to Buy Aphria Inc. (APHA) Stock

"I want to thank all Aphria Shareholders for voting and approving the Arrangement. We appreciate their support, as we believe the business combination will create a Combined Company with a strong financial profile, low-cost production, market share leading brands, distribution network and unique partnerships,” Simon stated. “The Combined Company will be increasingly well-positioned to deliver a sustainable attractive return for our combined shareholder base."

The closing of the deal still awaits customary conditions, such as court authorization and the approval of Tilray stockholders.

On Monday, Aphria shared its third-quarter earnings, reporting net revenue of CA$153.6 million ($122.5 million), up by 6.4% year-over-year, and sequentially down by 4.3%.

The company also posted positive adjusted EBITDA of CA$12.7 million, representing the eighth consecutive quarter of positive EBITDA.

Shares of Aphria traded down 1.6% at the time of the publication of this article.

 

 

 

 

Posted-In:

Cannabis News Markets

Related Articles

Why This Organigram Analyst Says It's A Good Time To Buy Cannabis Stock

Cannabis company Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) posted second-quarter earnings last week, with gross reve read more

Tilray Debuts In Portugal Ahead Of Merger With Aphria

Cannabis company Tilray Inc. (NASDAQ: TLRY) is poised to enter the Portugal market. read more

Cantor Analyst Raises Aphria And Tilray Price Targets Amid Merger

Cantor Fitzgerald analyst Pablo Zuanic expressed disappointment by Aphria Inc. (TSX: APHA) (NASDAQ: APHA) quarterly results in an analyst note published Friday. read more

Aphria Posts Higher Revenue, Plans To Close Tilray Deal In Q2

Aphria Inc. (TSX: APHA) (NASDAQ: APHA) posted net cannabis revenue of CA$67.9 million for the second quarter of 2021 — 99% higher than in the prior-year quarter. Overall, net revenue hovered CA$160.5 million ($126.6 million). That's up by 33% from the same period in fiscal 2020. read more